Tapewire

Nasdaq · USD

TPST

Tempest Therapeutics, Inc.

Export transactions ↓
Tapewire entity
7734
SEC CIK
0001544227
Parsed reports
237

Last 12 months

Inside the activity.

2 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202620
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 07, 2018 Filed Dec 11, 2018 19:37 UTC
FISHER MARYDirector
GrantCommon Stock 355 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-062108 · doc4.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,319

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F2 · shares: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.

F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F2 · balance_after: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.

Read SEC document
December 07, 2018 Filed Dec 12, 2018 00:42 UTC
KOZIN MARC DDirector
GrantCommon Stock 831 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-062119 · doc4.xml · nonDerivative · entry 1

KOZIN MARC D · CIK 0001241647 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,740

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F2 · shares: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.

F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F2 · balance_after: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.

Read SEC document
December 07, 2018 Filed Dec 11, 2018 19:30 UTC GrantCommon Stock 755 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-062104 · doc4.xml · nonDerivative · entry 1

ALDRICH RICHARD · CIK 0001185039 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,169

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F2 · shares: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.

F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F2 · balance_after: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.

Read SEC document
December 07, 2018 Filed Dec 11, 2018 19:49 UTC GrantStock Option (right to buy) · Derivative 3,720 Not disclosed Strike: $16.40 Not disclosed
Disclosure

SEC source: 0001209191-18-062127 · doc4.xml · derivative · entry 3

WHITCOMB RANDALL W · CIK 0001218867 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,720

Underlying: Common Stock · 3,720 shares

Expires 2028-08-23

F5 · price: Received in connection with the Merger in exchange for a stock option to acquire 50,000 shares of Millendo common stock for $1.22 per share.

F4 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on August 20, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
December 07, 2018 Filed Dec 11, 2018 19:49 UTC GrantStock Option (right to buy) · Derivative 21,438 Not disclosed Strike: $4.44 Not disclosed
Disclosure

SEC source: 0001209191-18-062127 · doc4.xml · derivative · entry 2

WHITCOMB RANDALL W · CIK 0001218867 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,438

Underlying: Common Stock · 21,438 shares

Expires 2026-01-27

F3 · price: Received in connection with the Merger in exchange for a stock option to acquire 288,152 shares of Millendo common stock for $0.33 per share.

F2 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on January 28, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
December 07, 2018 Filed Dec 11, 2018 19:49 UTC GrantCommon Stock 15,784 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-062127 · doc4.xml · nonDerivative · entry 1

WHITCOMB RANDALL W · CIK 0001218867 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,784

F1 · price: Received in exchange for 212,163 shares of Millendo Therapeutics, Inc. ("Millendo") common stock in connection with merger of Millendo Therapeutics, Inc. into the Issuer (the "Merger").

Read SEC document
December 07, 2018 Filed Dec 12, 2018 00:38 UTC GrantCommon Stock 23,684 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-062111 · doc4.xml · nonDerivative · entry 2

Gallagher Carol Giltner · CIK 0001329959 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By: Gallagher Revocable Trust

Disclosed balance after: 23,684

F2 · price: Received in exchange for 318,335 shares of Millendo Therapeutics, Inc. common stock in connection with merger of Millendo Therapeutics, Inc. into the Issuer.

Read SEC document
December 07, 2018 Filed Dec 12, 2018 00:38 UTC GrantCommon Stock 8,249 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-062111 · doc4.xml · nonDerivative · entry 1

Gallagher Carol Giltner · CIK 0001329959 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,249

F1 · price: Received in exchange for 110,887 shares of Millendo Therapeutics, Inc. common stock in connection with merger of Millendo Therapeutics, Inc. into the Issuer.

Read SEC document
December 07, 2018 Filed Dec 12, 2018 00:40 UTC GrantStock Option (right to buy) · Derivative 18,600 Not disclosed Strike: $16.40 Not disclosed
Disclosure

SEC source: 0001209191-18-062116 · doc4.xml · derivative · entry 1

Hedley Mary Lynne · CIK 0001340823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,600

Underlying: Common Stock · 18,600 shares

Expires 2028-08-23

F2 · price: Received in connection with the merger of Millendo Therapeutics, Inc. ("Millendo") into the Issuer in exchange for a stock option to acquire 250,000 shares of Millendo common stock for $1.22 per share.

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on February 24, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
December 07, 2018 Filed Dec 12, 2018 00:48 UTC
Mohideen PharisChief Medical Officer
GrantEmployee Stock Option (right to buy) · Derivative 40,919 Not disclosed Strike: $16.40 Not disclosed
Disclosure

SEC source: 0001209191-18-062125 · doc4.xml · derivative · entry 4

Mohideen Pharis · CIK 0001760395 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,919

Underlying: Common Stock · 40,919 shares

Expires 2028-08-23

F7 · price: Received in connection with the Merger in exchange for a stock option to acquire 550,000 shares of Millendo common stock for $1.22 per share.

F6 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on August 20, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
December 07, 2018 Filed Dec 12, 2018 00:48 UTC
Mohideen PharisChief Medical Officer
GrantEmployee Stock Option (right to buy) · Derivative 37,485 Not disclosed Strike: $4.44 Not disclosed
Disclosure

SEC source: 0001209191-18-062125 · doc4.xml · derivative · entry 3

Mohideen Pharis · CIK 0001760395 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,485

Underlying: Common Stock · 37,485 shares

Expires 2026-01-27

F5 · price: Received in connection with the Merger in exchange for a stock option to acquire 503,847 shares of Millendo common stock for $0.33 per share.

F4 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on January 28, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
December 07, 2018 Filed Dec 12, 2018 00:48 UTC
Mohideen PharisChief Medical Officer
GrantEmployee Stock Option (right to buy) · Derivative 19,258 Not disclosed Strike: $2.69 Not disclosed
Disclosure

SEC source: 0001209191-18-062125 · doc4.xml · derivative · entry 2

Mohideen Pharis · CIK 0001760395 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,258

Underlying: Common Stock · 19,258 shares

Expires 2024-12-04

F3 · price: Received in connection with the Merger in exchange for a stock option to acquire 258,845 shares of Millendo common stock for $0.20 per share.

F2 · derivative.exercise_date: Fully vested.

Read SEC document
December 07, 2018 Filed Dec 12, 2018 00:48 UTC
Mohideen PharisChief Medical Officer
GrantCommon Stock 7,440 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-062125 · doc4.xml · nonDerivative · entry 1

Mohideen Pharis · CIK 0001760395 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,440

F1 · price: Received in exchange for 100,000 shares of Millendo Therapeutics, Inc. ("Millendo") common stock in connection with merger of Millendo Therapeutics, Inc. into the Issuer (the "Merger").

Read SEC document
December 07, 2018 Filed Dec 12, 2018 00:41 UTC GrantStock Option (right to buy) · Derivative 3,720 Not disclosed Strike: $16.40 Not disclosed
Disclosure

SEC source: 0001209191-18-062117 · doc4.xml · derivative · entry 2

Hindman James M. · CIK 0001617615 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,720

Underlying: Common Stock · 3,720 shares

Expires 2028-08-23

F4 · price: Received in connection with the Merger in exchange for a stock option to acquire 50,000 shares of Millendo common stock for $1.22 per share.

F3 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on August 20, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
December 07, 2018 Filed Dec 12, 2018 00:41 UTC GrantStock Option (right to buy) · Derivative 17,509 Not disclosed Strike: $6.59 Not disclosed
Disclosure

SEC source: 0001209191-18-062117 · doc4.xml · derivative · entry 1

Hindman James M. · CIK 0001617615 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,509

Underlying: Common Stock · 17,509 shares

Expires 2026-08-09

F2 · price: Received in connection with the merger of Millendo Therapeutics, Inc. ("Millendo") into the Issuer (the "Merger") in exchange for a stock option to acquire 235,341 shares of Millendo common stock for $0.49 per share.

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on June 17, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
September 28, 2018 Filed Oct 2, 2018 18:03 UTC
FISHER MARYDirector
GrantCommon Stock 6,851 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-011955 · edgar.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,460

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

Read SEC document
September 28, 2018 Filed Oct 2, 2018 22:03 UTC
KOZIN MARC DDirector
GrantCommon Stock 16,014 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-011956 · edgar.xml · nonDerivative · entry 1

KOZIN MARC D · CIK 0001241647 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,647

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $11,687.50 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $11,687.50 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

Read SEC document
September 28, 2018 Filed Oct 2, 2018 18:03 UTC GrantCommon Stock 14,558 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-011954 · edgar.xml · nonDerivative · entry 1

ALDRICH RICHARD · CIK 0001185039 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,220

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

Read SEC document
July 04, 2018 Filed Jul 6, 2018 18:33 UTC
FISHER MARYDirector
GrantStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0001179110-18-009534 · edgar.xml · derivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2028-07-04

F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following July 4, 2018.

Read SEC document
July 04, 2018 Filed Jul 6, 2018 22:34 UTC
KOZIN MARC DDirector
GrantStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0001179110-18-009536 · edgar.xml · derivative · entry 1

KOZIN MARC D · CIK 0001241647 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2028-07-04

F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following July 4, 2018.

Read SEC document
July 04, 2018 Filed Jul 6, 2018 22:32 UTC GrantStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0001179110-18-009533 · edgar.xml · derivative · entry 1

CAPELLO JEFFREY D · CIK 0001224108 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2028-07-04

F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following July 4, 2018.

Read SEC document
July 04, 2018 Filed Jul 6, 2018 18:31 UTC GrantStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0001179110-18-009532 · edgar.xml · derivative · entry 1

ALDRICH RICHARD · CIK 0001185039 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2028-07-04

F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following July 4, 2018.

Read SEC document
July 04, 2018 Filed Jul 6, 2018 18:33 UTC GrantStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0001179110-18-009535 · edgar.xml · derivative · entry 1

HOWE JOHN P MD · CIK 0001190348 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2028-07-04

F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following July 4, 2018.

Read SEC document
July 04, 2018 Filed Jul 6, 2018 22:34 UTC
Sexton JohnDirector
GrantStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0001179110-18-009537 · edgar.xml · derivative · entry 1

Sexton John · CIK 0001640938 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2028-07-04

F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following July 4, 2018.

Read SEC document
June 29, 2018 Filed Jul 3, 2018 16:37 UTC
FISHER MARYDirector
GrantCommon Stock 5,510 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-009348 · edgar.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,609

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

Read SEC document
June 29, 2018 Filed Jul 3, 2018 20:38 UTC
KOZIN MARC DDirector
GrantCommon Stock 12,880 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-009350 · edgar.xml · nonDerivative · entry 1

KOZIN MARC D · CIK 0001241647 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,633

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $11,687.50 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $11,687.50 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

Read SEC document
June 29, 2018 Filed Jul 3, 2018 16:35 UTC GrantCommon Stock 11,709 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-009346 · edgar.xml · nonDerivative · entry 1

ALDRICH RICHARD · CIK 0001185039 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,662

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

Read SEC document
May 10, 2018 Filed Dec 12, 2018 00:43 UTC
Kroeger Christopher A.Chief Executive Officer
GrantEmployee Stock Option (right to buy) · Derivative 47,666 $0.00 Strike: $13.98 $0.00
Disclosure

SEC source: 0001209191-18-062120 · doc4.xml · derivative · entry 1

Kroeger Christopher A. · CIK 0001658918 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,666

Underlying: Common Stock · 47,666 shares

Expires 2028-05-10

F1 · derivative.exercise_price: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.

F1 · shares: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.

F2 · derivative.exercise_date: The Reporting Person has the right to exercise these options for a three-year period after any termination of his employment (other than for cause).

F1 · derivative.underlying_shares: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.

F1 · balance_after: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.

Read SEC document
May 10, 2018 Filed Dec 12, 2018 00:46 UTC
Lillie James WoodruffChief Scientific Officer
GrantEmployee Stock Option (right to buy) · Derivative 8,333 $0.00 Strike: $13.98 $0.00
Disclosure

SEC source: 0001209191-18-062124 · doc4.xml · derivative · entry 1

Lillie James Woodruff · CIK 0001728746 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,333

Underlying: Common Stock · 8,333 shares

Expires 2028-05-10

F1 · derivative.exercise_price: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.

F1 · shares: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.

F2 · derivative.exercise_date: The Reporting Person has the right to exercise these options for a three-year period after any termination of his employment (other than for cause).

F1 · derivative.underlying_shares: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.

F1 · balance_after: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.

Read SEC document
May 10, 2018 Filed Dec 12, 2018 00:39 UTC
GILLIS JONATHANSenior Vice President, Finance
GrantEmployee Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $13.98 $0.00
Disclosure

SEC source: 0001209191-18-062113 · doc4.xml · derivative · entry 1

GILLIS JONATHAN · CIK 0001709954 · Senior Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2028-05-10

F1 · derivative.exercise_price: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.

F1 · shares: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.

F2 · derivative.exercise_date: The Reporting Person has the right to exercise these options for a three-year period after any termination of his employment (other than for cause).

F1 · derivative.underlying_shares: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.

F1 · balance_after: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.

Read SEC document
March 30, 2018 Filed Apr 3, 2018 17:25 UTC
FISHER MARYDirector
GrantCommon Stock 6,165 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-005302 · edgar.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,099

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

Read SEC document
March 30, 2018 Filed Apr 3, 2018 21:26 UTC
KOZIN MARC DDirector
GrantCommon Stock 14,411 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-005303 · edgar.xml · nonDerivative · entry 1

KOZIN MARC D · CIK 0001241647 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,753

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $11,687.50 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $11,687.50 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

Read SEC document
March 30, 2018 Filed Apr 3, 2018 17:25 UTC GrantCommon Stock 13,101 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-005301 · edgar.xml · nonDerivative · entry 1

ALDRICH RICHARD · CIK 0001185039 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,953

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

Read SEC document
March 06, 2018 Filed Mar 6, 2018 22:56 UTC
Lillie James WoodruffChief Scientific Officer
GrantStock Option (right to buy) · Derivative 357,057 $0.00 Strike: $1.02 $0.00
Disclosure

SEC source: 0001179110-18-003673 · edgar.xml · derivative · entry 1

Lillie James Woodruff · CIK 0001728746 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 357,057

Underlying: Common Stock · 357,057 shares

Expires 2028-03-05

F1 · derivative.exercise_date: The shares underlying this option shall vest as to 25% of the shares on the first anniversary of the commencement of the Reporting Person's employment (which began on January 16, 2018), with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

Read SEC document
February 08, 2018 Filed Feb 9, 2018 23:23 UTC
GILLIS JONATHANSenior Vice President, Finance
GrantStock Option (right to buy) · Derivative 128,645 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0001179110-18-001912 · edgar.xml · derivative · entry 1

GILLIS JONATHAN · CIK 0001709954 · Senior Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,645

Underlying: Common Stock · 128,645 shares

Expires 2028-02-08

F1 · derivative.exercise_date: The option shall vest as to 25% of the shares on February 8, 2019 and the remaining shares shall vest in equal quarterly installments over 12 quarters, ending February 8, 2022.

Read SEC document
December 29, 2017 Filed Jan 3, 2018 20:37 UTC
FISHER MARYDirector
GrantCommon Stock 3,571 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-000449 · edgar.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,934

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

Read SEC document
December 29, 2017 Filed Jan 4, 2018 01:42 UTC
KOZIN MARC DDirector
GrantCommon Stock 8,348 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-000450 · edgar.xml · nonDerivative · entry 1

KOZIN MARC D · CIK 0001241647 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,342

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $11,687.50 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $11,687.50 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

Read SEC document
December 29, 2017 Filed Jan 3, 2018 20:34 UTC GrantCommon Stock 7,589 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-000448 · edgar.xml · nonDerivative · entry 1

ALDRICH RICHARD · CIK 0001185039 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,852

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

Read SEC document
September 29, 2017 Filed Oct 3, 2017 19:48 UTC
FISHER MARYDirector
GrantCommon Stock 3,521 $0.00 $0.00
Disclosure

SEC source: 0001179110-17-013054 · edgar.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,363

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

Read SEC document
September 29, 2017 Filed Oct 3, 2017 23:47 UTC
KOZIN MARC DDirector
GrantCommon Stock 8,230 $0.00 $0.00
Disclosure

SEC source: 0001179110-17-013053 · edgar.xml · nonDerivative · entry 1

KOZIN MARC D · CIK 0001241647 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,994

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

Read SEC document
September 29, 2017 Filed Oct 3, 2017 19:46 UTC GrantCommon Stock 7,482 $0.00 $0.00
Disclosure

SEC source: 0001179110-17-013052 · edgar.xml · nonDerivative · entry 1

ALDRICH RICHARD · CIK 0001185039 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,263

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

Read SEC document
June 30, 2017 Filed Jul 5, 2017 19:12 UTC
FISHER MARYDirector
GrantCommon Stock 3,205 $0.00 $0.00
Disclosure

SEC source: 0001179110-17-010100 · edgar.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,842

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

Read SEC document
June 30, 2017 Filed Jul 5, 2017 23:11 UTC
KOZIN MARC DDirector
GrantCommon Stock 6,477 $0.00 $0.00
Disclosure

SEC source: 0001179110-17-010099 · edgar.xml · nonDerivative · entry 1

KOZIN MARC D · CIK 0001241647 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,764

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

Read SEC document
June 30, 2017 Filed Jul 5, 2017 19:11 UTC GrantCommon Stock 6,810 $0.00 $0.00
Disclosure

SEC source: 0001179110-17-010098 · edgar.xml · nonDerivative · entry 1

ALDRICH RICHARD · CIK 0001185039 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,781

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

Read SEC document
June 21, 2017 Filed Jun 23, 2017 20:57 UTC
FISHER MARYDirector
GrantStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $1.46 $0.00
Disclosure

SEC source: 0001179110-17-009557 · edgar.xml · derivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2027-06-21

F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following June 21, 2017.

Read SEC document
June 21, 2017 Filed Jun 24, 2017 00:55 UTC
KOZIN MARC DDirector
GrantStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $1.46 $0.00
Disclosure

SEC source: 0001179110-17-009552 · edgar.xml · derivative · entry 1

KOZIN MARC D · CIK 0001241647 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2027-06-21

F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following June 21, 2017.

Read SEC document
June 21, 2017 Filed Jun 24, 2017 00:56 UTC GrantStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $1.46 $0.00
Disclosure

SEC source: 0001179110-17-009555 · edgar.xml · derivative · entry 1

CAPELLO JEFFREY D · CIK 0001224108 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2027-06-21

F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following June 21, 2017.

Read SEC document
June 21, 2017 Filed Jun 23, 2017 20:57 UTC GrantStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $1.46 $0.00
Disclosure

SEC source: 0001179110-17-009556 · edgar.xml · derivative · entry 1

ALDRICH RICHARD · CIK 0001185039 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2027-06-21

F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following June 21, 2017.

Read SEC document
June 21, 2017 Filed Jun 23, 2017 20:56 UTC GrantStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $1.46 $0.00
Disclosure

SEC source: 0001179110-17-009554 · edgar.xml · derivative · entry 1

HOWE JOHN P MD · CIK 0001190348 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2027-06-21

F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following June 21, 2017.

Read SEC document
June 21, 2017 Filed Jun 24, 2017 00:56 UTC
Sexton JohnDirector
GrantStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $1.46 $0.00
Disclosure

SEC source: 0001179110-17-009553 · edgar.xml · derivative · entry 1

Sexton John · CIK 0001640938 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2027-06-21

F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following June 21, 2017.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.